Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;33(2):103-8.
doi: 10.1007/BF01742537.

Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity

Affiliations

Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacity

D M Finkelstein et al. Cancer Immunol Immunother. 1991.

Abstract

We compared the ability of murine lymphokine-activated killer (LAK) cells grown in either a serum-supplemented "standard" medium (alpha MEM plus fetal calf serum) or a serum-free medium (AIM-V) to lyse a range of tumour targets. LAK cells grown in either of the media killed a cultured murine tumour line (YAC-1 lymphoma) well and spared syngeneic "self" cells (concanavalin-A-stimulated splenocytes). However, a striking difference was noted in the ability of LAK cells grown in alpha MEM plus fetal calf serum (as opposed to AIM-V) to kill "modified self" cells (trinitrophenol-modified concanavalin A blasts); LAK cells grown in the former always killed modified self cells better than those grown in the latter. This pattern held under a broad range of experimental manipulations and was found to be related to a relative increase in CD3-bearing LAK cells grown in the standard medium. These data suggest that the two media cannot be used interchangeably. This conclusion may have clinical implications for the use of LAK cells, as animal studies have been done using LAK cells generated in serum-containing medium and clinical studies have used LAK cells generated in serum-free medium.

PubMed Disclaimer

Similar articles

References

    1. Ballas ZK, Rasmussen W, Van Otegham JK. Lymphokine-activated killer (LAK) cells: II. Delineation of distinct murine LAK-precursor subpopulations. J Immunol. 1987;138:1647. - PubMed
    1. Ballas ZK, Rasmussen W. Lymphokine-activated killer (LAK) cells: IV. Characterization of murine LAK effector subpopulations. J Immunol. 1990;144:386. - PubMed
    1. Chadwick BS, Miller RG. Heterogeneity of the lymphokine-activated killer cell phenotype. Cell Immunol. 1991;132:168. - PubMed
    1. Froelich CJ, Guiffaut S. Induction of lymphokine activated killer cells in serum-free medium. J Immunol Methods. 1986;86:205. - PubMed
    1. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982;155:1823. - PMC - PubMed

Publication types

LinkOut - more resources